Investigation of inhaled Salmeterol/ Fluticasone propionate (SFC) in patient with COPD.
Phase 4
- Conditions
- Chronic obstructive pulmonary disease
- Registration Number
- JPRN-UMIN000006589
- Lead Sponsor
- Hamamatsu University School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 342
Inclusion Criteria
Not provided
Exclusion Criteria
History of hyper- sensitivity to Salmeterol/ Fluticasone propionate Patients with bronchial asthma Patients during acute exacerbation Presence of infectious disease, pneumothorax, and severe heart failure
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Changes of FEV1
- Secondary Outcome Measures
Name Time Method QOL, Safety